Physician profile
Anna Elisa Muzio
NPI 1023538717
$9,617.32
in general payments reported to CMS, 2019-2025
13 companies · $1,117 in 2025
The $1,117 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $428 · 2021: $213 · 2022: $1,927 · 2023: $3,537 · 2024: $2,394 · 2025: $1,117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,316 · Food and Beverage: $1,733.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,315.75 |
| Food and Beverage | $1,733.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,913.06 | 2023-2025 | |
| Novus Surgical Consultants | $2,225.59 | 2023-2025 | |
| Axogen | $1,747.79 | 2022-2025 | |
| Skeletal Dynamics INC | $1,412.19 | 2023-2024 | Ijs, Implate, Geminus |
| Medical Device Business Services, INC. | $299.99 | 2019 | |
| Stryker Corporation | $281.23 | 2019-2023 | Accolade |
| Djo, LLC | $197.22 | 2023 | Donjoy |
| Zimmer Biomet Holdings, INC. | $195.97 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $123.48 | 2022 | |
| Sanara Medtech INC. | $119.68 | 2023 | Celleraterx |
| Smith+Nephew, INC. | $57.26 | 2022 | |
| Avanos Medical | $23.81 | 2023 | On-Q* Pump and Accessories |
| Depuy Synthes Sales INC. | $20.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Elisa Muzio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.